A Dose-Ranging Study of Pegylated Interferon Alfa-2b and Ribavirin in Chronic Hepatitis C

Glue, Paul; Rouzier‐Panis, Régine; Raffanel, C; Sabo, Ron; K. Gupta, Samir; Salfi, Margaret; Jacobs, Shiela; P. Clement, Robert

doi:10.1053/jhep.2000.16661

Public

A Dose-Ranging Study of Pegylated Interferon Alfa-2b and Ribavirin in Chronic Hepatitis C

Published in Hepatology • Sep 1, 2000

Authors:

Paul Glue

Régine Rouzier‐Panis

C Raffanel

Abstract

The objectives of this study were to assess the safety, pharmacokinetics, and efficacy of pegylated interferon alfa-2b (PEG-Intron) plus ribavirin in patients with chronic hepatitis C. A total of 72 patients (35 men/37 women, age range 20-68 years) with clinically compensated chronic hepatitis C vir...

Subject

Ribavirin

Pegylated interferon

Medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!